These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 1950542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
    Wang JH, Devalia JL, Rusznak C, Bagnall A, Sapsford RJ, Davies RJ.
    Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
    [Abstract] [Full Text] [Related]

  • 3. Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.
    Erjefält JS, Greiff L, Andersson M, Matsson E, Petersen H, Linden M, Ansari T, Jeffery PK, Persson CG.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):304-12. PubMed ID: 10390416
    [Abstract] [Full Text] [Related]

  • 4. Eosinophils and eosinophil cationic protein in nasal lavages in allergen-induced hyperresponsiveness: effects of topical glucocorticosteroid treatment.
    Andersson M, Andersson P, Venge P, Pipkorn U.
    Allergy; 1989 Jul; 44(5):342-8. PubMed ID: 2669553
    [Abstract] [Full Text] [Related]

  • 5. Mucosal output of eotaxin in allergic rhinitis and its attenuation by topical glucocorticosteroid treatment.
    Greiff L, Petersen H, Mattsson E, Andersson M, Erjefält JS, Linden M, Svensson C, Persson CG.
    Clin Exp Allergy; 2001 Aug; 31(8):1321-7. PubMed ID: 11529904
    [Abstract] [Full Text] [Related]

  • 6. Effect of six-hour exposure to nitrogen dioxide on early-phase nasal response to allergen challenge in patients with a history of seasonal allergic rhinitis.
    Wang JH, Devalia JL, Duddle JM, Hamilton SA, Davies RJ.
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):669-76. PubMed ID: 7499684
    [Abstract] [Full Text] [Related]

  • 7. Measurement of inflammatory mediators of mast cells and eosinophils in native nasal lavage fluid in nasal polyposis.
    Di Lorenzo G, Drago A, Esposito Pellitteri M, Candore G, Colombo A, Gervasi F, Pacor ML, Purello D'Ambrosio F, Caruso C.
    Int Arch Allergy Immunol; 2001 Jun; 125(2):164-75. PubMed ID: 11435734
    [Abstract] [Full Text] [Related]

  • 8. Changes in non-specific nasal reactivity and eosinophil influx and activation after allergen challenge.
    Klementsson H, Andersson M, Baumgarten CR, Venge P, Pipkorn U.
    Clin Exp Allergy; 1990 Sep; 20(5):539-47. PubMed ID: 2253085
    [Abstract] [Full Text] [Related]

  • 9. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
    Nielsen LP, Bjerke T, Christensen MB, Skamling M, Peterson CG, Mygind N, Dahl R.
    Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure.
    Roquat A, Ihre E, van Hage-Hamsten M, Halldén G, Zetterström O.
    Allergy; 1996 Jan; 51(1):42-8. PubMed ID: 8721527
    [Abstract] [Full Text] [Related]

  • 12. Monitoring nasal allergic inflammation by measuring the concentration of eosinophil cationic protein and eosinophils in nasal secretions.
    Wang D, Clement P, Smitz J, de Waele M, Derde MP.
    Allergy; 1995 Feb; 50(2):147-51. PubMed ID: 7604937
    [Abstract] [Full Text] [Related]

  • 13. Eosinophil cationic protein and specific IgE in serum and nasal mucosa of patients with grass-pollen-allergic rhinitis and asthma.
    Marcucci F, Sensi LG, Migali E, Coniglio G.
    Allergy; 2001 Mar; 56(3):231-6. PubMed ID: 11251403
    [Abstract] [Full Text] [Related]

  • 14. Effect of slow-release theophylline on nasal antigen challenge in subjects with allergic rhinitis.
    Aubier M, Neukirch C, Maachi M, Boucara D, Engelstätter R, Steinijans V, Samoyeau R, Dehoux M.
    Eur Respir J; 1998 May; 11(5):1105-10. PubMed ID: 9648963
    [Abstract] [Full Text] [Related]

  • 15. Albumin, bradykinins, and eosinophil cationic protein on the nasal mucosal surface in patients with hay fever during natural allergen exposure.
    Svensson C, Andersson M, Persson CG, Venge P, Alkner U, Pipkorn U.
    J Allergy Clin Immunol; 1990 May; 85(5):828-33. PubMed ID: 2332562
    [Abstract] [Full Text] [Related]

  • 16. Eosinophil inflammation of the nasal mucosa in allergic and non-allergic rhinitis measured by eosinophil cationic protein levels in native nasal fluid and serum.
    Rasp G, Thomas PA, Bujía J.
    Clin Exp Allergy; 1994 Dec; 24(12):1151-6. PubMed ID: 7889429
    [Abstract] [Full Text] [Related]

  • 17. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G, Tosca MA, Passalacqua G, Canonica GW.
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [Abstract] [Full Text] [Related]

  • 18. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis.
    Bonay M, Neukirch C, Grandsaigne M, Leçon-Malas V, Ravaud P, Dehoux M, Aubier M.
    Allergy; 2006 Jan; 61(1):111-8. PubMed ID: 16364165
    [Abstract] [Full Text] [Related]

  • 19. Correlations between complaints, inflammatory cells and mediator concentrations in nasal secretions after nasal allergen challenge and during natural allergen exposure.
    Wang D, Clement P, Smitz J, De Waele M, Derde MP.
    Int Arch Allergy Immunol; 1995 Mar; 106(3):278-85. PubMed ID: 7888790
    [Abstract] [Full Text] [Related]

  • 20. Eosinophil cationic protein and myeloperoxidase in nasal secretion as markers of inflammation in allergic rhinitis.
    Linder A, Venge P, Deuschl H.
    Allergy; 1987 Nov; 42(8):583-90. PubMed ID: 2447809
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.